What Are AICIS, MOCRA, and CPNP, and Why Do They Matter for K-Beauty Brands?
AICIS, MOCRA, and CPNP are the cosmetic regulatory frameworks for Australia, the United States, and the European Union, respectively. If you plan to sell Korean-made skincare in any of these markets, you need to comply with the corresponding system before your product touches a shelf or a shipping box.
Here is the short version. Australia's AICIS regulates every chemical ingredient in your product. The US's MOCRA (Modernization of Cosmetics Regulation Act) requires facility registration, product listing, and adverse event reporting through the FDA. The EU's CPNP (Cosmetic Products Notification Portal) demands pre-market safety assessments, a designated Responsible Person based in the EU, and notification through a centralized portal.
Each system has different costs, different timelines, and different pain points. Getting this wrong does not just mean a fine. It can mean your shipment gets held at customs, your product gets pulled from marketplaces, or your brand takes a reputational hit you cannot recover from.
How Do the Three Systems Compare at a Glance?
The table below puts the key requirements side by side. Bookmark this one.
| Requirement | Australia (AICIS) | United States (MOCRA/FDA) | European Union (CPNP) |
|---|---|---|---|
| Governing law | Industrial Chemicals Act 2019 | MoCRA (amends FD&C Act), effective 2023 | EU Cosmetics Regulation (EC) No 1223/2009 |
| Regulatory body | AICIS (Dept. of Health) | FDA | European Commission + national authorities |
| Pre-market safety assessment | No (but ingredient-level review) | No (safety substantiation required, not pre-market approval) | Yes (CPSR required before market entry) |
| Facility registration | Yes (AICIS registration for importers/manufacturers) | Yes (FDA facility registration, renewed every 2 years) | No facility registration (but RP must be established in EU) |
| Product notification | No single product notification (ingredient-level categorization) | Yes (FDA product listing, updated annually) | Yes (CPNP notification before placing on market) |
| Responsible Person / Agent | Not required | US adverse-event contact on label (since Dec 2024) | Required (EU-based Responsible Person mandatory) |
| Banned substances | Poisons Standard (SUSMP) + AICIS restrictions | ~11 banned/restricted ingredients | 1,730+ prohibited substances (Annex II) |
| Adverse event reporting | Voluntary | Mandatory (15 business days for serious events) | Mandatory (serious undesirable effects) |
| GMP requirement | Not explicitly required for cosmetics | GMP rule pending (not yet finalized under MoCRA) | ISO 22716 GMP compliance expected |
| Annual reporting | Yes (annual declaration by Nov 30) | Yes (annual product listing updates) | No annual renewal (but must keep PIF current) |
What Does Australia's AICIS Actually Require from Cosmetic Importers?
AICIS takes a chemical-by-chemical approach. It does not regulate "cosmetic products" as a category. Instead, it regulates every industrial chemical ingredient inside your product. If you import or manufacture cosmetics in Australia, you must register with AICIS before introducing any industrial chemicals, and as of September 1, 2026, this registration requirement applies to all introducers (AICIS official site).
Each ingredient falls into one of six introduction categories:
| Category | Risk Level | What's Involved |
|---|---|---|
| Listed | Lowest | Ingredient is on the Australian Inventory. Minimal requirements. |
| Exempted | Low | Meets specific criteria (e.g., small volume). No pre-introduction report. |
| Reported | Low-Medium | Must submit a pre-introduction report to AICIS. |
| Assessed | Medium-High | AICIS conducts a risk assessment before you can introduce. |
| Commercial Evaluation | Variable | For chemicals introduced solely for commercial evaluation purposes. |
| Exceptional Circumstances | Variable | Emergency or special-case introductions. |
For most standard K-beauty ingredients (hyaluronic acid, niacinamide, centella asiatica extract), you will find them already on the Australian Inventory as "listed" chemicals. The work comes when your formula includes newer or less common ingredients that may need a reported or assessed introduction.
2026 update: AICIS changed the rules for retinal (retinaldehyde) as of June 27, 2026. It can no longer be imported under the exempted or reported categories for consumer cosmetic use. You now need an AICIS assessment certificate first (Certified Cosmetics). If your K-beauty line includes retinal products, this directly affects your Australia launch timeline.
Registration costs: the application fee for 2026-27 is AUD 85, with annual levy charges based on an 8-level structure tied to your total chemical introduction value (AICIS fee consultation). For 2026-27 specifically, AICIS is offering a 90% discount on the registration levy.
What Does the US MOCRA Framework Require?
MOCRA, signed into law in December 2022, is the biggest overhaul of US cosmetic regulation in over 80 years. Before MOCRA, the FDA had almost no mandatory oversight of cosmetics. Now, the requirements are real and enforceable.
Here is your compliance checklist for selling K-beauty products in the US:
| Requirement | Details | Deadline / Frequency |
|---|---|---|
| Facility Registration | Register every manufacturing and processing facility with FDA | Renewed every 2 years |
| Product Listing | List every cosmetic product with FDA, including ingredients | Updated annually |
| Adverse Event Reporting | Report serious adverse events to FDA | Within 15 business days |
| Safety Substantiation | Maintain adequate evidence that each product is safe | Ongoing |
| Label Requirements | Include a US adverse-event contact on packaging | Since December 29, 2024 |
| Fragrance Allergen Labeling | Disclose specific fragrance allergens on labels | Rule pending |
| GMP Compliance | Follow good manufacturing practices | Rule pending |
The good news: FDA charges $0 in government fees for facility registration and product listing (FDA.gov). The cost comes from compliance services if you use a third-party firm: roughly $849/year for facility registration and $200 per product listing through providers like FDA Registration Assistance (FDA Registration Assistance, March 2026).
As of January 6, 2026, the FDA had received 14,299 facility registrations and 992,907 product listings under MoCRA (Foley & Lardner, March 2026). The system is live and active. This is not something you can ignore.
For Korean ODM brands: your Korean manufacturer's facility does not need to register with the FDA unless they are directly exporting to the US. If you import through a US-based entity, that entity's facility (even if it is a fulfillment warehouse) may need registration. Check with a regulatory consultant for your specific supply chain setup. (More on K-beauty brand regulatory setup)
A note from Liz, founder of ALTA MEET
I'm Liz, I run ALTA MEET from Manhattan, NYC. Regulatory compliance is the part of launching a K-beauty brand that nobody finds exciting, but it is the part that can shut you down fastest if you get it wrong.
The most common mistake I see from indie founders: assuming that if your Korean ODM handled regulatory for the Korean market (MFDS/KFDA), your product is automatically compliant in the US, EU, or Australia. It is not. Each market has its own requirements, its own banned ingredient lists, and its own labeling rules. A product that is fully legal in Korea might contain an ingredient that is restricted in the EU or require notification paperwork you have not filed with the FDA.
If you are sorting out which markets to launch in first and what the regulatory cost looks like for each, grab 15 minutes on my calendar. We will map out the compliance steps for your specific situation.
What Makes the EU CPNP System the Most Demanding of the Three?
The EU system is the strictest. No debate. It requires a full safety assessment before your product can legally enter the market, and it bans over 1,730 substances compared to roughly 11 under the FDA (Esko, 2026).
Here is what EU compliance involves:
Responsible Person (RP): You must appoint an EU-based Responsible Person who is legally accountable for your product. The RP holds the Product Information File (PIF), submits the CPNP notification, and acts as the contact for regulatory authorities. If you are not based in the EU, you cannot do this yourself. You need a partner or service provider.
Cosmetic Product Safety Report (CPSR): A qualified safety assessor must review your formula and produce a CPSR before you can sell. This is not a checkbox exercise. It involves toxicological profiles of every ingredient, exposure calculations, and a formal safety conclusion.
CPNP Notification: Before placing the product on the EU market, the RP notifies through the CPNP portal. The portal itself is free, but the cost of RP services, CPSR preparation, and compliance consulting adds up. Budget approximately GBP 300 to 500 per SKU for full CPNP compliance, or GBP 1,500 to 2,500 for a batch of five SKUs (Eldris, 2026).
Banned ingredients: The EU operates on the precautionary principle. Any substance classified as carcinogenic, mutagenic, or toxic to reproduction (CMR) is automatically prohibited unless specifically exempted. This is why the banned list is so much longer than the US list. For K-beauty brands, this means checking every single ingredient in your Korean ODM formula against Annex II. Ingredients that are perfectly legal in Korea or the US may be prohibited in the EU.
Which Market Should an Indie K-Beauty Founder Enter First?
There is no universal right answer, but here is a practical framework based on cost, complexity, and market opportunity:
| Factor | Australia (AICIS) | United States (MOCRA) | European Union (CPNP) |
|---|---|---|---|
| Regulatory cost (first SKU) | Low (AUD 85 registration + levy) | Low-Medium ($0 FDA fees; ~$1,000+ with consultants) | High (GBP 300-500 per SKU for RP + CPSR + CPNP) |
| Time to compliance | 2 to 4 weeks (if ingredients are listed) | 2 to 6 weeks | 6 to 12 weeks (CPSR alone takes 4-8 weeks) |
| Complexity | Medium (ingredient-level, not product-level) | Medium (straightforward but paperwork-heavy) | High (safety assessment, RP, PIF) |
| Market size (K-beauty) | Smaller but growing | Largest K-beauty import market | Large, price-sensitive |
| Best for | Brands with standard ingredients wanting a smaller test market | Brands wanting the biggest revenue opportunity | Brands with safety data ready and RP relationships |
For most indie K-beauty founders working with Korean ODMs, the US market is the most practical starting point: the regulatory cost is the lowest, the market is the largest, and the MOCRA requirements, while real, are manageable without a local representative.
Australia works well as a secondary or test market, particularly if your ingredients are already on the AICIS inventory. The EU is the most expensive and complex to enter, but it also signals credibility. If you can pass EU compliance, you can sell almost anywhere.
A phased approach makes sense for most founders: launch in the US first, add Australia, then tackle the EU once you have revenue and can invest in the RP and CPSR costs. (Low MOQ K-beauty manufacturing playbook)
Frequently Asked Questions
Do I need a separate product registration for each country?
Yes. AICIS, MOCRA, and CPNP are completely independent systems. Compliance in one country does not carry over to another. You need to meet each market's specific requirements separately, including facility registration (US), ingredient categorization (Australia), and CPNP notification with a Responsible Person (EU).
Can my Korean ODM handle regulatory compliance for me?
Some Korean ODMs offer regulatory support, but coverage varies. Most can help with Korean MFDS/KFDA compliance and provide technical documentation. However, market-specific compliance (FDA registration, AICIS categorization, EU CPSR and RP appointment) typically requires additional specialists in the target country.
What happens if I sell cosmetics in the US without MOCRA registration?
Non-compliance can result in FDA warning letters, product detentions at the border, and potential injunctions. The FDA now has explicit authority to mandate recalls. While enforcement is still ramping up, marketplace platforms like Amazon are increasingly requiring proof of MOCRA compliance.
How much does it cost to appoint an EU Responsible Person?
EU RP services typically cost GBP 300 to 500 per SKU, which usually includes CPNP notification, PIF maintenance, and regulatory contact. For five SKUs, budget approximately GBP 1,500 to 2,500 for the full package including the CPSR (Eldris, 2026).
Are K-beauty ingredients like snail mucin or centella asiatica restricted in any of these markets?
Snail mucin and centella asiatica extract are generally permitted in all three markets. However, always verify each ingredient against the specific market's restricted lists. The EU's Annex II is the most extensive with 1,730+ prohibited substances, so ingredients common in Korean formulations should be cross-checked against it.
Ready to Launch Your K-Beauty Brand in Multiple Markets?
Regulatory compliance feels overwhelming when you look at three systems at once. But taken one market at a time, it is entirely doable, even for a solo founder. Start with the market that fits your budget and supply chain, nail the compliance, build revenue, and expand from there.
If you want help mapping out the regulatory path for your specific product line and target markets, book a free gut-check call with Liz. Fifteen minutes to get clarity on your next move.
By Liz Song, founder of ALTA MEET
